A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment

PURPOSE: Raloxifene is a selective estrogen receptor modulator (SERM), and raloxifene treatment for osteoporosis is reimbursable under the Korean National Health Insurance. Evidence suggests that SERMs use reduces the risk of breast cancer in Asian population. Herein, we retrospectively investigated...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Breast Cancer
Main Authors: Lee, Jihyoun, Lee, Ji Sung, Lee, Jong Eun, Kim, Zisun, Han, Sun Wook, Hur, Sung Mo, Choi, Young Jin, Park, Sungmin
格式: Artigo
語言:Inglês
出版: Korean Breast Cancer Society 2021
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250100/
https://ncbi.nlm.nih.gov/pubmed/34128366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e28
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍